Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06516016

Multimodal Markers of Neurodegenerative Disorders at Presymptomatic Stages

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
Paris Brain Institute (ICM) · Academic / Other
Sex
All
Age
18 Years – 95 Years
Healthy volunteers
Accepted

Summary

NeuroPrems is a prospective, monocentric, longitudinal, not relating to a medicinal product for human use, non-randomized, non-controlled research. The study mainly aims to identify longitudinal changes and events in multimodal markers of neurodegeneration and neuroinflammation during the presymptomatic phases of neurodegenerative diseases.

Conditions

Interventions

TypeNameDescription
RADIATIONPET\[18F\]DPA-714 will be injected intravenously as a 1 minute intravenous bolus injection and dynamic PET acquisition will last 90 min. The aim is the quantification of the neuroimmune reaction during neuroinflammation process.
OTHERMRI 3TBrain MRI will aim at providing imaging biomarkers which will allow evaluating brain structure, microstructure, iron load, myelin, neurodegeneration of the substantia nigra and locus coeruleus, functional connectivity, brain perfusion and the glymphatic system.
OTHEROculomotricity assessmentRecording eye movements in a controlled environment (requiring no specific room or area) in binocular vision at a frequency \> 500Hz, while retaining infrared video footage of eye movements for high-quality clinical monitoring.
OTHERMagnetoencephalography assessmentRecording brain magnetic activity using the Elekta Neuromag® TRIUX Magnetoencephalograph ; The participant will be comfortably seated in an adjustable-height chair. The device is enclosed in a shielded room isolated from external electric and magnetic fields to measure the extremely weak magnetic activities produced by the brain.
OTHERBody posture and gait assessmentThe acquisition of kinematic gait parameters will be achieved ; markers are positioned on the different segments of members, recognized by a camera system positioned on the walls. Neurophysiologic muscular activity of the lower limbs will also be recorded.
OTHERVoice recordingParticipants will be recorded during a single session at every visit upon baseline with a professional quality head mounted microphone.
OTHERVideo-polysomnographyParticipants will complete standard sleep questionnaires before the visit and perform neurophysiological tests including cognitive tasks before and after the sleep recording.
BIOLOGICALBlood sampling, skin biopsy, excreta sampling, lumbar punctureExperimental analyses, genetic and multi-OMIC analyses for biomarker research.

Timeline

Start date
2024-09-01
Primary completion
2034-08-31
Completion
2034-08-31
First posted
2024-07-23
Last updated
2024-07-23

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06516016. Inclusion in this directory is not an endorsement.